1,832 research outputs found
Notas sobre los artropodos que viven en el pijuayo (Bactris gasipaes H.B.K. : Palmae) en la Amazonia peruana
The peachpalm, #Bactris gasipaes$ H.B.K. is cultivated in the Amazon basin and in Central America for its fruits and for the production of heart palm. Several insects and mites attack it. Some observations in Peruvian Amazonia on those pests and other associated insects are reported. Some species are new for Peru. (Résumé d'auteur
Observations préliminaires sur les insectes nuisibles à l'araza (Eugenia stipitata McVaugh, Myrtaceae), nouvelle culture fruitière en Amazonie
L'araza (#Eugenia stipitata McVaugh, #Myrtaceae) est un arbuste fruitier amazonien récemment domestiqué, qui présente un fort potentiel agro-industriel. Afin d'inventorier les insectes nuisibles, des évaluations ont été entreprises entre 1988 et 1992 dans les plantations de trois centres de recherche et dans deux plantations privées, proches d'Iquitos, en Amazonie péruvienne. Neuf espèces nuisibles ont été identifiées dont cinq affectent les fruits, trois sont des défoliateurs et la dernière coupe les rameaux. Quatre de ces espèces sont considérées comme nuisibles : #Anastrepha obliqua, #Conotrachelus eugeniae et #Atractomerus immigrans, qui influent sur la qualité et le volume des fruits récoltés ainsi que #Plectrophoroides impressicollis qui peut détruire totalement les inflorescences. (Résume d'auteur
Los insectos plaga del camu camu (Myrciaria dubia H.B.K.) y del araza (Eugenia stipitata Mc Vaugh) identificacion y control
Le camu camu (#Myrciaria dubio H.B.K.) et l'araza (#Eugenia stipitata Mc Vaugh) sont des cultures nouvelles en Amazonie péruvienne. Dans ce travail sont citées 21 espèces d'insectes nuisibles au camu camu, parmi lesquelles 6 espèces doivent être considérées comme des ravageurs économiquement importants, ce sont : #Austrotachardiella sp, #Ceroplastes sp., #Conotrachelus sp.1., #Dysmicoccus brevipes Cock, #Tuthillia cognata Hodk. y #Xylosandrus compactus Heichh. Sur araza 9 espèces ont été répertoriées, dont 4 sont des ravageurs importants : #Anastrepha obliqua Macq., #Atractomerus immigrans Clark, #Conotrachelus sp. 2 y #Plectrophoroides impressicollis Chevr. Quelques espèces nouvelles pour la science ont été décrites récemment ou sont en cours d'étude. On donne les premières informations sur les espèces dont la biologie et l'écologie n'étaient pas connues, ainsi que des méthodes de contrôle adaptées au système de gestion des plantations. (Résumé d'auteur
Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States.
Hepatitis C virus (HCV) infection is common among people living with human immunodeficiency virus (PLWH). Extrahepatic manifestations of HCV, including myocardial infarction (MI), are a topic of active research. MI is classified into types, predominantly atheroembolic type 1 MI (T1MI) and supply-demand mismatch type 2 MI (T2MI). We examined the association between HCV and MI among patients in the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems, a US multicenter clinical cohort of PLWH. MIs were centrally adjudicated and categorized by type using the Third Universal Definition of Myocardial Infarction. We estimated the association between chronic HCV (RNA+) and time to MI while adjusting for demographic characteristics, cardiovascular risk factors, clinical characteristics, and history of injecting drug use. Among 23,407 PLWH aged ≥18 years, there were 336 T1MIs and 330 T2MIs during a median of 4.7 years of follow-up between 1998 and 2016. HCV was associated with a 46% greater risk of T2MI (adjusted hazard ratio (aHR) = 1.46, 95% confidence interval (CI): 1.09, 1.97) but not T1MI (aHR = 0.87, 95% CI: 0.58, 1.29). In an exploratory cause-specific analysis of T2MI, HCV was associated with a 2-fold greater risk of T2MI attributed to sepsis (aHR = 2.01, 95% CI: 1.25, 3.24). Extrahepatic manifestations of HCV in this high-risk population are an important area for continued research
Role of NiO in the nonlocal spin transport through thin NiO films on Y3Fe5 O12
In spin-transport experiments with spin currents propagating through an antiferromagnetic (AFM) material, the antiferromagnet is mainly treated as a passive spin conductor not generating nor adding any spin current to the system. The spin current transmissivity of the AFM NiO is affected by magnetic fluctuations, peaking at the Néel temperature and decreasing by lowering the temperature. To study the role of antiferromagnetism in local and nonlocal spin-transport experiments, we send spin currents through NiO of various thicknesses placed on Y3Fe5O12. The spin currents are injected either electrically or by thermal gradients and measured at a wide range of temperatures and magnetic field strengths. The transmissive role is reflected in the sign change of the local electrically injected signals and the decrease in signal strength of all other signals by lowering the temperature. The thermally generated signals, however, show an additional upturn below 100K that is unaffected by an increased NiO thickness. A change in the thermal conductivity could affect these signals. The temperature and magnetic field dependence are similar to those for bulk NiO, indicating that NiO itself contributes to thermally induced spin currents
Identification of Arabidopsis thaliana phloem RNAs provides a search criterion for phloem-based transcripts hidden in complex data sets of micro array experiments
Phloem-mobile signals play a major role in plant nutrition, development and communication. In the latter
context, phloem-mobile RNAs have been associated with signalling between plant tissues. In this study, we
focused on the identification of transcripts in the shoot phloem of the model plant Arabidopsis thaliana. To
isolate transcripts expressed in phloem parenchyma cells and in companion cell–sieve element complexes, we
used laser microdissection coupled to laser pressure catapulting (LMPC). Mobile transcripts in sieve elements
were isolated from leaf phloem exudates. After optimization of sampling and fixation, RNA of high quality was
isolated from both sources. The modifications to the RNA amplification procedure described here were well
suited to production of RNA of sufficient yield and quality for microarray experiments. Microarrays hybridized
with LMPC-derived phloem tissue or phloem sap RNA allowed differentiation between phloem-expressed and
mobile transcript species. Using this set of phloem transcripts and comparing them with microarrays derived
from databases of light, hormone and nutrient treatment experiments, we identified phloem-derived RNAs as
mobile, potential long-distance signals. Our dataset thus provides a search criterion for phloem-based signals
hidden in the complex datasets of microarray experiments. The availability of these comprehensive phloem
transcript profiles will facilitate reverse-genetic studies and forward-genetic screens for phloem and longdistance
RNA signalling mutants
Interaction between IRF6 and TGFA Genes Contribute to the Risk of Nonsyndromic Cleft Lip/Palate
Previous evidence from tooth agenesis studies suggested IRF6 and TGFA interact. Since tooth agenesis is commonly found in individuals with cleft lip/palate (CL/P), we used four large cohorts to evaluate if IRF6 and TGFA interaction contributes to CL/P. Markers within and flanking IRF6 and TGFA genes were tested using Taqman or SYBR green chemistries for case-control analyses in 1,000 Brazilian individuals. We looked for evidence of gene-gene interaction between IRF6 and TGFA by testing if markers associated with CL/P were overtransmitted together in the case-control Brazilian dataset and in the additional family datasets. Genotypes for an additional 142 case-parent trios from South America drawn from the Latin American Collaborative Study of Congenital Malformations (ECLAMC), 154 cases from Latvia, and 8,717 individuals from several cohorts were available for replication of tests for interaction. Tgfa and Irf6 expression at critical stages during palatogenesis was analyzed in wild type and Irf6 knockout mice. Markers in and near IRF6 and TGFA were associated with CL/P in the Brazilian cohort (p<10-6). IRF6 was also associated with cleft palate (CP) with impaction of permanent teeth (p<10-6). Statistical evidence of interaction between IRF6 and TGFA was found in all data sets (p = 0.013 for Brazilians; p = 0.046 for ECLAMC; p = 10-6 for Latvians, and p = 0.003 for the 8,717 individuals). Tgfa was not expressed in the palatal tissues of Irf6 knockout mice. IRF6 and TGFA contribute to subsets of CL/P with specific dental anomalies. Moreover, this potential IRF6-TGFA interaction may account for as much as 1% to 10% of CL/P cases. The Irf6-knockout model further supports the evidence of IRF6-TGFA interaction found in humans. © 2012 Letra et al
Hints for Small Disks around Very Low Mass Stars and Brown Dwarfs
The properties of disks around brown dwarfs and very low mass stars (hereafter VLMOs) provide important boundary conditions on the process of planet formation and inform us about the numbers and masses of planets than can form in this regime. We use the Herschel Space Observatory PACS spectrometer to measure the continuum and [O I] 63 μm line emission toward 11 VLMOs with known disks in the Taurus and Chamaeleon I star-forming regions. We fit radiative transfer models to the spectral energy distributions of these sources. Additionally, we carry out a grid of radiative transfer models run in a regime that connects the luminosity of our sources with brighter T Tauri stars. We find that VLMO disks with sizes 1.3-78 au, smaller than typical T Tauri disks, fit well the spectral energy distributions assuming that disk geometry and dust properties are stellar mass independent. Reducing the disk size increases the disk temperature, and we show that VLMOs do not follow previously derived disk temperature-stellar luminosity relationships if the disk outer radius scales with stellar mass. Only 2 out of 11 sources are detected in [O I] despite a better sensitivity than was achieved for T Tauri stars, suggesting that VLMO disks are underluminous. Using thermochemical models, we show that smaller disks can lead to the unexpected [O I] 63 μm nondetections in our sample. The disk outer radius is an important factor in determining the gas and dust observables. Hence, spatially resolved observations with ALMA—to establish if and how disk radii scale with stellar mass—should be pursued further. Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA
Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial
Background: In the INBUILD trial in patients with progressive fibrosing interstitial lung diseases (ILDs), nintedanib reduced the rate of decline in forced vital capacity compared with placebo, with side-effects that were manageable for most patients. We used data from the INBUILD trial to characterize further the safety and tolerability of nintedanib. Methods: Patients with fibrosing ILDs other than idiopathic pulmonary fibrosis (IPF), who had experienced progression of ILD within the 24 months before screening despite management deemed appropriate in clinical practice, were randomized to receive nintedanib 150 mg twice daily or placebo. To manage adverse events, treatment could be interrupted or the dose reduced to 100 mg twice daily. We assessed adverse events and dose adjustments over the whole trial. Results: A total of 332 patients received nintedanib and 331 received placebo. Median exposure to trial drug was 17.4 months in both treatment groups. Adverse events led to treatment discontinuation in 22.0% of patients treated with nintedanib and 14.5% of patients who received placebo. The most frequent adverse event was diarrhea, reported in 72.3% of patients in the nintedanib group and 25.7% of patients in the placebo group. Diarrhea led to treatment discontinuation in 6.3% of patients in the nintedanib group and 0.3% of the placebo group. In the nintedanib and placebo groups, respectively, 48.2% and 15.7% of patients had >= 1 dose reduction and/or treatment interruption. Serious adverse events were reported in 44.3% of patients in the nintedanib group and 49.5% of patients in the placebo group. The adverse event profile of nintedanib was generally consistent across subgroups based on age, sex, race and weight, but nausea, vomiting and dose reductions were more common among female than male patients. Conclusions: The adverse event profile of nintedanib in patients with progressive fibrosing ILDs other than IPF is consistent with its established safety and tolerability profile in patients with IPF and characterized mainly by gastrointestinal events, particularly diarrhea. Management of adverse events using symptomatic therapies and dose adjustment is important to minimize the impact of adverse events and help patients remain on therapy
- …